Annual EBITDA
$10.73 B
-$1.44 B-11.83%
31 December 2023
Summary:
Amgen annual earnings before interest, taxes, depreciation & amortization is currently $10.73 billion, with the most recent change of -$1.44 billion (-11.83%) on 31 December 2023. During the last 3 years, it has fallen by -$2.27 billion (-17.44%). AMGN annual EBITDA is now -17.44% below its all-time high of $13.00 billion, reached on 31 December 2020.AMGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$5.27 B
+$2.27 B+75.65%
30 September 2024
Summary:
Amgen quarterly earnings before interest, taxes, depreciation & amortization is currently $5.27 billion, with the most recent change of +$2.27 billion (+75.65%) on 30 September 2024. Over the past year, it has increased by +$1.67 billion (+46.43%). AMGN quarterly EBITDA is now at all-time high.AMGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$13.48 B
+$1.67 B+14.16%
30 September 2024
Summary:
Amgen TTM earnings before interest, taxes, depreciation & amortization is currently $13.48 billion, with the most recent change of +$1.67 billion (+14.16%) on 30 September 2024. Over the past year, it has dropped by -$1.34 billion (-9.03%). AMGN TTM EBITDA is now -9.03% below its all-time high of $14.82 billion, reached on 30 September 2023.AMGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -11.8% | +46.4% | -9.0% |
3 y3 years | -17.4% | +59.7% | +22.1% |
5 y5 years | -16.7% | +70.2% | +6.4% |
AMGN EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -17.4% | at low | at high | +144.7% | -9.0% | +22.1% |
5 y | 5 years | -17.4% | at low | at high | +211.3% | -9.0% | +22.1% |
alltime | all time | -17.4% | >+9999.0% | at high | +7764.2% | -9.0% | >+9999.0% |
Amgen EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.27 B(+75.6%) | $13.48 B(+14.2%) |
June 2024 | - | $3.00 B(+39.3%) | $11.81 B(-2.2%) |
Mar 2024 | - | $2.15 B(-29.4%) | $12.07 B(-18.4%) |
Dec 2023 | $10.73 B(-11.8%) | $3.05 B(-15.2%) | $14.80 B(-0.1%) |
Sept 2023 | - | $3.60 B(+10.4%) | $14.82 B(+0.0%) |
June 2023 | - | $3.26 B(-33.2%) | $14.82 B(+4.0%) |
Mar 2023 | - | $4.88 B(+58.9%) | $14.24 B(+17.0%) |
Dec 2022 | $12.17 B(+7.7%) | $3.07 B(-14.5%) | $12.17 B(-2.0%) |
Sept 2022 | - | $3.60 B(+33.9%) | $12.41 B(+2.4%) |
June 2022 | - | $2.69 B(-4.4%) | $12.12 B(+8.9%) |
Mar 2022 | - | $2.81 B(-15.3%) | $11.12 B(-1.5%) |
Dec 2021 | $11.30 B(-13.1%) | $3.32 B(+0.5%) | $11.30 B(+2.3%) |
Sept 2021 | - | $3.30 B(+94.9%) | $11.05 B(-1.0%) |
June 2021 | - | $1.69 B(-43.2%) | $11.15 B(-12.3%) |
Mar 2021 | - | $2.98 B(-2.8%) | $12.72 B(-2.2%) |
Dec 2020 | $13.00 B(+2.9%) | $3.07 B(-10.0%) | $13.00 B(+0.6%) |
Sept 2020 | - | $3.41 B(+4.7%) | $12.91 B(+2.5%) |
June 2020 | - | $3.26 B(-0.2%) | $12.60 B(-1.1%) |
Mar 2020 | - | $3.26 B(+9.3%) | $12.74 B(+0.9%) |
Dec 2019 | $12.63 B(-1.9%) | $2.99 B(-3.6%) | $12.63 B(-0.3%) |
Sept 2019 | - | $3.10 B(-8.8%) | $12.67 B(+1.2%) |
June 2019 | - | $3.40 B(+7.8%) | $12.53 B(-0.6%) |
Mar 2019 | - | $3.15 B(+4.1%) | $12.61 B(-2.1%) |
Dec 2018 | $12.88 B(+0.2%) | $3.03 B(+2.6%) | $12.88 B(+0.2%) |
Sept 2018 | - | $2.95 B(-15.2%) | $12.85 B(-1.7%) |
June 2018 | - | $3.48 B(+1.5%) | $13.07 B(+0.7%) |
Mar 2018 | - | $3.43 B(+14.5%) | $12.97 B(+0.9%) |
Dec 2017 | $12.86 B(+2.6%) | $3.00 B(-5.5%) | $12.86 B(-1.3%) |
Sept 2017 | - | $3.17 B(-6.2%) | $13.03 B(-0.6%) |
June 2017 | - | $3.38 B(+2.1%) | $13.11 B(+2.7%) |
Mar 2017 | - | $3.31 B(+4.4%) | $12.77 B(+1.9%) |
Dec 2016 | $12.53 B(+12.0%) | $3.17 B(-2.3%) | $12.53 B(+3.6%) |
Sept 2016 | - | $3.25 B(+6.8%) | $12.10 B(+2.1%) |
June 2016 | - | $3.04 B(-1.1%) | $11.85 B(+2.1%) |
Mar 2016 | - | $3.07 B(+12.2%) | $11.60 B(+3.8%) |
Dec 2015 | $11.18 B(+27.8%) | $2.74 B(-8.6%) | $11.18 B(+6.3%) |
Sept 2015 | - | $3.00 B(+7.3%) | $10.51 B(+8.8%) |
June 2015 | - | $2.79 B(+5.3%) | $9.67 B(+2.6%) |
Mar 2015 | - | $2.65 B(+28.0%) | $9.42 B(+7.7%) |
Dec 2014 | $8.75 B(+15.5%) | $2.07 B(-3.6%) | $8.75 B(+4.2%) |
Sept 2014 | - | $2.15 B(-15.6%) | $8.39 B(+1.2%) |
June 2014 | - | $2.55 B(+28.5%) | $8.29 B(+8.1%) |
Mar 2014 | - | $1.98 B(+15.2%) | $7.67 B(+1.3%) |
Dec 2013 | $7.57 B(+5.9%) | $1.72 B(-16.1%) | $7.57 B(+3.2%) |
Sept 2013 | - | $2.05 B(+6.5%) | $7.34 B(+3.2%) |
June 2013 | - | $1.92 B(+2.1%) | $7.11 B(-0.8%) |
Mar 2013 | - | $1.88 B(+26.6%) | $7.17 B(+0.3%) |
Dec 2012 | $7.15 B(+22.9%) | $1.49 B(-18.3%) | $7.15 B(-0.3%) |
Sept 2012 | - | $1.82 B(-8.1%) | $7.17 B(+15.2%) |
June 2012 | - | $1.98 B(+6.6%) | $6.23 B(+4.4%) |
Mar 2012 | - | $1.86 B(+23.4%) | $5.97 B(+2.5%) |
Dec 2011 | $5.82 B(-16.1%) | $1.51 B(+71.8%) | $5.82 B(+1.5%) |
Sept 2011 | - | $877.00 M(-49.1%) | $5.74 B(-14.3%) |
June 2011 | - | $1.72 B(+0.5%) | $6.70 B(-2.0%) |
Mar 2011 | - | $1.71 B(+20.5%) | $6.83 B(-0.3%) |
Dec 2010 | $6.94 B(+1.6%) | $1.42 B(-22.6%) | $6.85 B(-0.8%) |
Sept 2010 | - | $1.84 B(-1.3%) | $6.91 B(-1.6%) |
June 2010 | - | $1.86 B(+7.4%) | $7.02 B(+1.5%) |
Mar 2010 | - | $1.73 B(+17.6%) | $6.92 B(+1.3%) |
Dec 2009 | $6.83 B(+2.9%) | $1.47 B(-24.4%) | $6.83 B(-4.1%) |
Sept 2009 | - | $1.95 B(+10.9%) | $7.12 B(+2.9%) |
June 2009 | - | $1.76 B(+6.9%) | $6.92 B(+4.8%) |
Mar 2009 | - | $1.65 B(-6.6%) | $6.60 B(-0.5%) |
Dec 2008 | $6.64 B(+11.0%) | $1.76 B(+0.7%) | $6.64 B(+3.0%) |
Sept 2008 | - | $1.75 B(+21.3%) | $6.44 B(+6.5%) |
June 2008 | - | $1.44 B(-14.1%) | $6.05 B(+0.5%) |
Mar 2008 | - | $1.68 B(+7.2%) | $6.02 B(+0.6%) |
Dec 2007 | $5.98 B(-0.9%) | $1.57 B(+15.5%) | $5.98 B(-12.5%) |
Sept 2007 | - | $1.36 B(-3.9%) | $6.83 B(-3.6%) |
June 2007 | - | $1.41 B(-14.1%) | $7.08 B(-3.3%) |
Mar 2007 | - | $1.64 B(-32.1%) | $7.33 B(+2.7%) |
Dec 2006 | $6.03 B(+6.1%) | $2.42 B(+50.4%) | $7.13 B(+18.2%) |
Sept 2006 | - | $1.61 B(-2.7%) | $6.03 B(+1.8%) |
June 2006 | - | $1.65 B(+13.8%) | $5.93 B(+2.5%) |
Mar 2006 | - | $1.45 B(+10.2%) | $5.78 B(+1.7%) |
Dec 2005 | $5.69 B(+22.7%) | $1.32 B(-12.2%) | $5.69 B(-5.7%) |
Sept 2005 | - | $1.50 B(-0.5%) | $6.04 B(+15.8%) |
June 2005 | - | $1.51 B(+11.2%) | $5.21 B(+6.6%) |
Mar 2005 | - | $1.36 B(-18.5%) | $4.89 B(+5.5%) |
Dec 2004 | $4.64 B | $1.67 B(+145.0%) | $4.64 B(+18.8%) |
Sept 2004 | - | $680.00 M(-42.7%) | $3.90 B(-8.1%) |
June 2004 | - | $1.19 B(+7.4%) | $4.25 B(+4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2004 | - | $1.10 B(+18.5%) | $4.05 B(+7.2%) |
Dec 2003 | $3.78 B(+42.4%) | $932.00 M(-9.1%) | $3.78 B(+3.2%) |
Sept 2003 | - | $1.03 B(+3.8%) | $3.66 B(+10.1%) |
June 2003 | - | $988.50 M(+18.8%) | $3.32 B(+12.0%) |
Mar 2003 | - | $832.00 M(+2.1%) | $2.97 B(+11.8%) |
Dec 2002 | $2.65 B(+47.7%) | $815.00 M(+18.2%) | $2.65 B(+25.2%) |
Sept 2002 | - | $689.40 M(+9.2%) | $2.12 B(+8.5%) |
June 2002 | - | $631.50 M(+21.9%) | $1.95 B(+6.2%) |
Mar 2002 | - | $518.10 M(+85.0%) | $1.84 B(+2.3%) |
Dec 2001 | $1.80 B(+13.7%) | $280.10 M(-46.4%) | $1.80 B(-3.8%) |
Sept 2001 | - | $522.90 M(+1.0%) | $1.87 B(+4.6%) |
June 2001 | - | $517.70 M(+8.7%) | $1.79 B(+6.3%) |
Mar 2001 | - | $476.40 M(+35.7%) | $1.68 B(+3.5%) |
Dec 2000 | $1.58 B(+5.2%) | $351.10 M(-20.2%) | $1.62 B(-1.7%) |
Sept 2000 | - | $440.10 M(+7.0%) | $1.65 B(+2.8%) |
June 2000 | - | $411.30 M(-2.0%) | $1.60 B(+1.9%) |
Mar 2000 | - | $419.70 M(+10.8%) | $1.58 B(+4.9%) |
Dec 1999 | $1.50 B(+19.0%) | $378.80 M(-4.1%) | $1.50 B(+3.1%) |
Sept 1999 | - | $395.00 M(+3.5%) | $1.46 B(+4.8%) |
June 1999 | - | $381.60 M(+10.2%) | $1.39 B(+4.7%) |
Mar 1999 | - | $346.40 M(+3.8%) | $1.33 B(+5.2%) |
Dec 1998 | $1.26 B(+20.5%) | $333.60 M(+1.6%) | $1.26 B(+7.6%) |
Sept 1998 | - | $328.30 M(+2.8%) | $1.17 B(+7.4%) |
June 1998 | - | $319.40 M(+13.7%) | $1.09 B(+3.0%) |
Mar 1998 | - | $280.90 M(+15.0%) | $1.06 B(+1.3%) |
Dec 1997 | $1.05 B(+3.1%) | $244.20 M(-1.5%) | $1.05 B(-1.0%) |
Sept 1997 | - | $247.90 M(-13.8%) | $1.06 B(-1.1%) |
June 1997 | - | $287.70 M(+7.5%) | $1.07 B(+2.2%) |
Mar 1997 | - | $267.60 M(+5.0%) | $1.05 B(+4.5%) |
Dec 1996 | $1.02 B(+20.3%) | $254.90 M(-1.7%) | $1.00 B(+3.5%) |
Sept 1996 | - | $259.40 M(-2.0%) | $967.10 M(+3.1%) |
June 1996 | - | $264.80 M(+19.1%) | $937.70 M(+5.3%) |
Mar 1996 | - | $222.30 M(+0.8%) | $890.50 M(+5.4%) |
Dec 1995 | $845.00 M(+9.3%) | $220.60 M(-4.1%) | $845.00 M(+1.3%) |
Sept 1995 | - | $230.00 M(+5.7%) | $834.10 M(+3.4%) |
June 1995 | - | $217.60 M(+23.1%) | $806.60 M(+3.3%) |
Mar 1995 | - | $176.80 M(-15.7%) | $781.10 M(+1.0%) |
Dec 1994 | $773.00 M(+28.4%) | $209.70 M(+3.6%) | $773.30 M(+8.4%) |
Sept 1994 | - | $202.50 M(+5.4%) | $713.70 M(+5.9%) |
June 1994 | - | $192.10 M(+13.7%) | $673.80 M(+6.3%) |
Mar 1994 | - | $169.00 M(+12.6%) | $634.10 M(+5.3%) |
Dec 1993 | $601.90 M(+13.2%) | $150.10 M(-7.7%) | $602.00 M(-8.3%) |
Sept 1993 | - | $162.60 M(+6.7%) | $656.30 M(+5.5%) |
June 1993 | - | $152.40 M(+11.3%) | $621.90 M(+7.6%) |
Mar 1993 | - | $136.90 M(-33.0%) | $577.90 M(+8.7%) |
Dec 1992 | $531.70 M(+266.9%) | $204.40 M(+59.4%) | $531.80 M(+28.5%) |
Sept 1992 | - | $128.20 M(+18.3%) | $413.70 M(+16.3%) |
June 1992 | - | $108.40 M(+19.4%) | $355.70 M(+99.3%) |
Mar 1992 | - | $90.80 M(+5.2%) | $178.50 M(+23.2%) |
Dec 1991 | $144.90 M(+110.6%) | $86.30 M(+22.9%) | $144.90 M(+331.3%) |
Sept 1991 | - | $70.20 M(-202.0%) | $33.60 M(-295.3%) |
June 1991 | - | -$68.80 M(-220.3%) | -$17.20 M(-125.0%) |
Mar 1991 | - | $57.20 M(-328.8%) | $68.80 M(+164.6%) |
Mar 1991 | $68.80 M(+67.4%) | - | - |
Dec 1990 | - | -$25.00 M(-228.9%) | $26.00 M(-60.4%) |
Sept 1990 | - | $19.40 M(+12.8%) | $65.70 M(+21.9%) |
June 1990 | - | $17.20 M(+19.4%) | $53.90 M(+31.5%) |
Mar 1990 | $41.10 M(+1184.4%) | $14.40 M(-2.0%) | $41.00 M(-213.3%) |
Dec 1989 | - | $14.70 M(+93.4%) | -$36.20 M(+22.3%) |
Sept 1989 | - | $7.60 M(+76.7%) | -$29.60 M(+66.3%) |
June 1989 | - | $4.30 M(-106.8%) | -$17.80 M(+270.8%) |
Mar 1989 | $3.20 M(-313.3%) | -$62.80 M(-394.8%) | -$4.80 M(-135.3%) |
Dec 1988 | - | $21.30 M(+9.8%) | $13.60 M(+130.5%) |
Sept 1988 | - | $19.40 M(+12.1%) | $5.90 M(-755.6%) |
June 1988 | - | $17.30 M(-139.0%) | -$900.00 K(-83.9%) |
Mar 1988 | -$1.50 M(-225.0%) | -$44.40 M(-426.5%) | -$5.60 M(-132.7%) |
Dec 1987 | - | $13.60 M(+7.9%) | $17.10 M(+51.3%) |
Sept 1987 | - | $12.60 M(0.0%) | $11.30 M(+135.4%) |
June 1987 | - | $12.60 M(-158.1%) | $4.80 M(-469.2%) |
Mar 1987 | $1.20 M(-25.0%) | -$21.70 M(-378.2%) | -$1.30 M(-127.7%) |
Dec 1986 | - | $7.80 M(+27.9%) | $4.70 M(+135.0%) |
Sept 1986 | - | $6.10 M(-6.2%) | $2.00 M(-41.2%) |
June 1986 | - | $6.50 M(-141.4%) | $3.40 M(-950.0%) |
Mar 1986 | $1.60 M(-118.8%) | -$15.70 M(-407.8%) | -$400.00 K(-150.0%) |
Dec 1985 | - | $5.10 M(-32.0%) | $800.00 K(-129.6%) |
Sept 1985 | - | $7.50 M(+177.8%) | -$2.70 M(-69.0%) |
June 1985 | - | $2.70 M(-118.6%) | -$8.70 M(-17.1%) |
Mar 1985 | -$8.50 M(+16.4%) | -$14.50 M(-1006.3%) | -$10.50 M(+66.7%) |
Dec 1984 | - | $1.60 M(+6.7%) | -$6.30 M(-20.3%) |
Sept 1984 | - | $1.50 M(+66.7%) | -$7.90 M(-16.0%) |
June 1984 | - | $900.00 K(-108.7%) | -$9.40 M(-8.7%) |
Mar 1984 | -$7.30 M | -$10.30 M | -$10.30 M |
FAQ
- What is Amgen annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Amgen?
- What is Amgen annual EBITDA year-on-year change?
- What is Amgen quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Amgen?
- What is Amgen quarterly EBITDA year-on-year change?
- What is Amgen TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Amgen?
- What is Amgen TTM EBITDA year-on-year change?
What is Amgen annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of AMGN is $10.73 B
What is the all time high annual EBITDA for Amgen?
Amgen all-time high annual earnings before interest, taxes, depreciation & amortization is $13.00 B
What is Amgen annual EBITDA year-on-year change?
Over the past year, AMGN annual earnings before interest, taxes, depreciation & amortization has changed by -$1.44 B (-11.83%)
What is Amgen quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AMGN is $5.27 B
What is the all time high quarterly EBITDA for Amgen?
Amgen all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.27 B
What is Amgen quarterly EBITDA year-on-year change?
Over the past year, AMGN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.67 B (+46.43%)
What is Amgen TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AMGN is $13.48 B
What is the all time high TTM EBITDA for Amgen?
Amgen all-time high TTM earnings before interest, taxes, depreciation & amortization is $14.82 B
What is Amgen TTM EBITDA year-on-year change?
Over the past year, AMGN TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.34 B (-9.03%)